Spyre Therapeutics (SYRE) had the highest return between June 10, 2023 and July 1, 2023 by a mid-cap US stock, returning 231.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Spyre Therapeutics (SYRE) | 6/10/2023 - 7/1/2023 | 231.62% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 6/10/2023 - 7/1/2023 | 119.18% |
Vera Therapeutics (VERA) | 6/10/2023 - 7/1/2023 | 86.63% |
TMC the metals (TMC) | 6/10/2023 - 7/1/2023 | 75.27% |
Hut 8 Corp Common Stock (HUT) | 6/10/2023 - 7/1/2023 | 74.6% |
Immunome (IMNM) | 6/10/2023 - 7/1/2023 | 66.18% |
Opendoor Technologies (OPEN) | 6/10/2023 - 7/1/2023 | 65.43% |
Eos Energy Enterprises (EOSE) | 6/10/2023 - 7/1/2023 | 53.9% |
SoundHound AI (SOUN) | 6/10/2023 - 7/1/2023 | 50.17% |
Terawulf (WULF) | 6/10/2023 - 7/1/2023 | 36.72% |
Sotera Health (SHC) | 6/10/2023 - 7/1/2023 | 28.25% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 6/10/2023 - 7/1/2023 | 28.16% |
Galaxy Digital (GLXY) | 6/10/2023 - 7/1/2023 | 28.02% |
Manchester United (MANU) | 6/10/2023 - 7/1/2023 | 27.24% |
Generac (GNRC) | 6/10/2023 - 7/1/2023 | 27.23% |
Quantumscape (QS) | 6/10/2023 - 7/1/2023 | 26.03% |
Cipher Mining (CIFR) | 6/10/2023 - 7/1/2023 | 25.99% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 6/10/2023 - 7/1/2023 | 25.51% |
Aurora Innovation (AUR) | 6/10/2023 - 7/1/2023 | 24.58% |
nCino (NCNO) | 6/10/2023 - 7/1/2023 | 24.51% |
RH (RH) | 6/10/2023 - 7/1/2023 | 24.37% |
CommScope (COMM) | 6/10/2023 - 7/1/2023 | 23.46% |
Norwegian Cruise Line (NCLH) | 6/10/2023 - 7/1/2023 | 23.34% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 6/10/2023 - 7/1/2023 | 22.23% |
IPG Photonics (IPGP) | 6/10/2023 - 7/1/2023 | 21.98% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
